Cancer treatments, despite their transformative potential, often come with unintended cardiovascular risks. Cardio-oncology focuses on understanding and mitigating these risks through a combination of cutting-edge diagnostics and personalized care. By using technologies like cardiac MRI and strain imaging, clinicians can detect early signs of heart stress caused by therapies such as radiation or targeted treatments. This collaborative field not only emphasizes prevention but also explores innovative therapeutics to repair heart damage. As survival rates improve, the integration of cardio-oncology ensures long-term health, enabling patients to overcome cancer without compromising cardiovascular wellness.
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : Finite-Element and Electromagnetic Cardio-Vascular Simulation for Drug Testing, Monitoring, and Safety Projection Using Bansal B–Bio Framework
Abhishek Bansal, New Era Consultancy Services, India
Title : Lipid and High-Density Lipoprotein (HDL) Subfraction Changes in Premenopausal and Postmenopausal Women with Breast Cancer Receiving Hormonal Therapy
Sofra Maria, Aretaieion University Hospital, Greece
Title : Sex-Specific Metabolic Reprogramming by Nanoemulsified Policosanol-Simvastatin Combinations: Synergistic Regulation of the IIS Pathway and BMM-Mediated Lipolysis in a Drosophila Model of Metabolic Syndrome
Lawal Kayode Olatunji, Usmanu Danfodiyo University Sokoto, Nigeria
Title : Intact Right Sinus of Valsalva Aneurysm Dissecting the Interventricular Septum: A Rare Cause of Complete Heart Block in Post-Mitral Valve Replacement
Keval Ajay Shah, APOLLO HOSPITAL NAVI MUMBAI, India